Blog

Event

Signal Detection and Management

2024-09-02

Share

Signal detection and management is a critical component of pharmacovigilance, focused on the identification, evaluation, and subsequent action on safety signals—information about new or known adverse events potentially caused by a medicine that may warrant further investigation.

This proactive process is essential for the continuous monitoring of a medicine’s safety profile, ensuring that any potential risks are managed effectively and efficiently.

At Arithmos, we understand the importance of robust signal detection and management in maintaining patient safety and meeting regulatory obligations.

We support Marketing Authorisation Holders by vigilantly monitoring a wide range of sources, including spontaneous reports, clinical studies, and scientific literature, to detect new information that could indicate a safety issue with a medicinal product.

Our services are designed to comply with EU legal requirements, providing end-to-end support for Marketing Authorisation Holders.

We assist in:

  • Monitoring: Diligently observing various data sources to identify potential safety signals.

 

  • Evaluation: Assessing the information to determine the need for further investigation.

 

  • Risk Management: Writing and updating Risk Management Plans (RMPs) as new data emerges, ensuring a dynamic response to the evolving safety landscape of medicines.

 

By partnering with Arithmos, you gain access to our expertise in navigating the complexities of signal detection and management.

Get an assessment

Contact us now to receive further information and an assessment from our experts. We will work with you to evaluate the best approach for your business processes.

From our resources